245 related articles for article (PubMed ID: 17608639)
1. High incidence of newly-developed gastroesophageal reflux disease in the Japanese community: a 6-year follow-up study.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2008 Mar; 23(3):393-7. PubMed ID: 17608639
[TBL] [Abstract][Full Text] [Related]
2. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
3. Genotypic and functional roles of IL-1B and IL-1RN on the risk of gastroesophageal reflux disease: the presence of IL-1B-511*T/IL-1RN*1 (T1) haplotype may protect against the disease.
Chourasia D; Achyut BR; Tripathi S; Mittal B; Mittal RD; Ghoshal UC
Am J Gastroenterol; 2009 Nov; 104(11):2704-13. PubMed ID: 19603010
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori infection and gastroesophageal reflux in a population-based study (The HUNT Study).
Nordenstedt H; Nilsson M; Johnsen R; Lagergren J; Hveem K
Helicobacter; 2007 Feb; 12(1):16-22. PubMed ID: 17241296
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan.
Fujiwara Y; Higuchi K; Watanabe Y; Shiba M; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Nishikawa H; Arakawa T
J Gastroenterol Hepatol; 2005 Jan; 20(1):26-9. PubMed ID: 15610442
[TBL] [Abstract][Full Text] [Related]
6. [Dynamic monitoring of serum pepsinogen among high risk populations of gastric cancer in Zhuanghe county].
Sun LP; Gong YH; Wang L; Gong W; Yuan Y
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(40):2826-30. PubMed ID: 17200016
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori and gastroesophageal reflux disease.
Garrido Serrano A; Lepe Jiménez JA; Guerrero Igea FJ; Perianes Hernández C
Rev Esp Enferm Dig; 2003 Nov; 95(11):788-90, 785-7. PubMed ID: 14640876
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of symptomatic gastro-oesophageal reflux disease in Japanese patients with peptic ulcer disease after eradication of Helicobacter pylori infection.
Yamamori K; Fujiwara Y; Shiba M; Watanabe T; Tominaga K; Oshitani N; Matsumoto T; Higuchi K; Arakawa T
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():107-11. PubMed ID: 15298615
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of celiac disease, Helicobacter pylori and gastroesophageal reflux in patients with refractory iron deficiency anemia.
Fayed SB; Aref MI; Fathy HM; Abd El Dayem SM; Emara NA; Maklof A; Shafik A
J Trop Pediatr; 2008 Feb; 54(1):43-53. PubMed ID: 17908698
[TBL] [Abstract][Full Text] [Related]
10. Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis.
Yaghoobi M; Farrokhyar F; Yuan Y; Hunt RH
Am J Gastroenterol; 2010 May; 105(5):1007-13; quiz 1006, 1014. PubMed ID: 20087334
[TBL] [Abstract][Full Text] [Related]
11. Helicobacter pylori seropositivity predicts outcomes of acid suppression therapy for laryngopharyngeal reflux symptoms.
Oridate N; Takeda H; Yamamoto J; Asaka M; Mesuda Y; Nishizawa N; Mori M; Furuta Y; Fukuda S
Laryngoscope; 2006 Apr; 116(4):547-53. PubMed ID: 16585857
[TBL] [Abstract][Full Text] [Related]
12. Preservation of gastric acid secretion may be important for the development of gastroesophageal junction adenocarcinoma in Japanese people, irrespective of the H. pylori infection status.
Inomata Y; Koike T; Ohara S; Abe Y; Sekine H; Iijima K; Ariizumi K; Yamagishi H; Kitagawa Y; Imatani A; Shimosegawa T
Am J Gastroenterol; 2006 May; 101(5):926-33. PubMed ID: 16573782
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori, ethnicity, and the gastroesophageal reflux disease spectrum: a study from the East.
Rajendra S; Ackroyd R; Robertson IK; Ho JJ; Karim N; Kutty KM
Helicobacter; 2007 Apr; 12(2):177-83. PubMed ID: 17309756
[TBL] [Abstract][Full Text] [Related]
14. [A study on the relationship of Helicobacter pylori, gastrin and gastroesophageal reflux disease].
Feng GJ; Hu FL; Wang HH; Liu JX
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):96-9. PubMed ID: 12812673
[TBL] [Abstract][Full Text] [Related]
15. Review article: influence of Helicobacter pylori on gastro-oesophageal reflux disease in Japan.
Haruma K
Aliment Pharmacol Ther; 2004 Dec; 20 Suppl 8():40-4. PubMed ID: 15575872
[TBL] [Abstract][Full Text] [Related]
16. Non-cardiac chest pain: the long-term natural history and comparison with gastroesophageal reflux disease.
Williams JF; Sontag SJ; Schnell T; Leya J
Am J Gastroenterol; 2009 Sep; 104(9):2145-52. PubMed ID: 19513020
[TBL] [Abstract][Full Text] [Related]
17. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
18. The changing epidemiology of GERD: geography and Helicobacter pylori.
Graham DY
Am J Gastroenterol; 2003 Jul; 98(7):1462-70. PubMed ID: 12873564
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and endoscopic progression of gastroesophageal reflux disease.
Garrido Serrano A; Guerrero Igea FJ; Lepe Jiménez JA; Perianes Hernández C
Rev Esp Enferm Dig; 2003 Oct; 95(10):712-6, 707-11. PubMed ID: 14588065
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of Helicobacter pylori infection in patients with gastroesophageal reflux disease].
Klitorakis I; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):80-4. PubMed ID: 20509280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
